China Shineway Pharmaceutical Group Limited (FRA:C1S)

Market Cap	613.78M
Revenue (ttm)	499.95M
Net Income (ttm)	111.17M
Shares Out	n/a
EPS (ttm)	0.15
PE Ratio	5.52
Forward PE	6.03
Dividend	0.06 (7.05%)
Ex-Dividend Date	Apr 30, 2025

Volume	880
Average Volume	1,216
Open	0.7950
Previous Close	0.8100
Day's Range	0.7950 - 0.7950
52-Week Range	0.7850 - 1.2600
Beta	n/a
RSI	33.38
Earnings Date	May 2, 2025

About FRA:C1S

China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong. The company offers Chinese medicines in the form of injection, soft capsules, and granules; tablets, pills, oral liquid, and powder; and traditional Chinese medicine granules in various therapeutic areas, including respiratory system disease, nervous system, digestive system disease, cardiovascular and cerebrovascular, ortho...

• Industry: Pharmaceutical Preparations
• Founded: 2002
• Employees: 3,220
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: C1S

Financial Performance

In 2024, FRA:C1S's revenue was 3.78 billion, a decrease of -16.35% compared to the previous year's 4.52 billion. Earnings were 840.05 million, a decrease of -13.35%.

Financial numbers in CNY